Gossamer Bio, Inc. (GOSS)

CIK 1728117 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Gossamer Bio, Inc..

Recent SEC filings

FiledFormAccession number
Nov 6, 2026SCHEDULE 13G0000315066-26-002941
Oct 29, 2026SCHEDULE 13D/A0001104659-26-120319
Oct 28, 20268-K0001728117-26-000109
Oct 8, 2026SCHEDULE 13D/A0001104659-26-114792
Sep 28, 20268-K0001728117-26-000106
Sep 28, 2026SCHEDULE 13D/A0001104659-26-111463
Sep 25, 202640001628280-26-063616
Sep 25, 202640001628280-26-063610
Sep 25, 202640001628280-26-063593
Sep 25, 202640001628280-26-063606
Sep 25, 202640001628280-26-063619
Sep 25, 202640001628280-26-063624
Sep 25, 202640001628280-26-063601
Sep 23, 20268-K0001728117-26-000104
Sep 22, 202630001628280-26-063097
Sep 16, 20268-K0001728117-26-000101
Sep 16, 2026DEF 14A0001728117-26-000102
Sep 11, 20268-K0001728117-26-000094
Sep 9, 20268-K0001728117-26-000091
Sep 4, 2026D0001728117-26-000088
Sep 3, 2026PRE 14A0001728117-26-000086
Sep 3, 20268-K0001728117-26-000085
Aug 26, 202640002003059-26-000008
Aug 26, 202640001740847-26-000006
Aug 26, 202640001857256-26-000006